Immunomodulatory oligonucleotides

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7088 (2006.01) A61K 31/7084 (2006.01) A61P 37/06 (2006.01) C12Q 1/68 (2006.01)

Patent

CA 2560114

Oligonucleotides containing unmethylated CpG dinucleotides and therapeutic utilities based on their ability to stimulate an immune response in a subject are disclosed. Also disclosed are therapies for treating diseases associated with immune system activation that are initiated by unmethylated CpG dinucleotides in a subject comprising administering to the subject oligonucleotides that do not contain unmethylated CpG sequences (i.e. methylated CpG sequences or no CpG sequence) to outcompete unmethylated CpG nucleic acids for binding. Further disclosed are methylated CpG containing dinucleotides for use in antisense therapies or as in vivo hybridization probes, and immunoinhibitory oligonucleotides for use as antiviral therapeutics.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Immunomodulatory oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunomodulatory oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunomodulatory oligonucleotides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1619122

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.